Tissue plasminogen activator for the treatment of intraventricular hematoma: The dose–effect relationship
- 1 October 2002
- journal article
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 202 (1-2), 35-41
- https://doi.org/10.1016/s0022-510x(02)00243-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protectionJournal of Neurosurgery, 1999
- Secondary Hemorrhage after Intraventricular Fibrinolysis: A Cautionary Note: A Report of Two CasesNeurosurgery, 1998
- Ventricular Dilatation in Experimental Intraventricular Hemorrhage in PigsStroke, 1997
- Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus.Archives of Disease in Childhood: Fetal & Neonatal, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Stereotactic Puncture and Lysis of Spontaneous Intracerebral Hemorrhage Using Recombinant Tissue-Plasminogen ActivatorNeurosurgery, 1995
- Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in ratsJournal of Neurosurgery, 1994
- Fibrinolytic activity in experimental intracerebral hematomaJournal of Neurosurgery, 1988
- Intraventricular hemorrhage from ruptured aneurysmJournal of Neurosurgery, 1983